Diverticulitis Disease Market Analysis, Trends, Growth, Research And Forecast 2033

Ring in the New Year with Exclusive Discounts from The Business Research Company! Enjoy a 33% markdown on our Opportunities and Strategies Reports and a fantastic 25% off on our Global Market Reports. Don't miss out on this limited-time offer to gain valuable insights and stay ahead in your industry.

The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033.

The Business Research Company's Diverticulitis Disease Global Market Report 2023 identifies rising demand for drugs and treatments for digestive disorders as the major driver for the diverticulitis disease market's growth in the forecast period. Digestive disorders refer to a wide range of conditions that affect the digestive system, which is responsible for breaking down and absorbing nutrients from food. Digestive disorders, such as colorectal cancer, can increase the risk of diverticulitis by contributing to the formation of diverticula and promoting bacterial stagnation in the colon's pouches.

The diverticulitis disease market size has grown rapidly in recent years. It will grow from $1.68 billion in 2023 to $1.85 billion in 2024 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to aging population, dietary habits, obesity, advancements in medical imaging.
The diverticulitis disease market size is expected to see strong growth in the next few years. It will grow to $2.65 billion in 2028 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to colonoscopy and endoscopy, increased awareness, minimally invasive procedures, personalized medicine. Major trends in the forecast period include preventive measures, enhanced diagnostic tools, collaborative care models, healthcare policy changes.

Download Free Sample Of Diverticulitis Disease Market Report -https://www.thebusinessresearchcompany.com/sample_request?id=12990&type=smp

Major competitors in the diverticulitis disease market are Pfizer Inc., Johnson and Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Company, Cipla Limited, Hikma Pharmaceuticals PLC, Endo Pharmaceuticals, Aspen Pharmacare, Zydus Lifesciences, Lupin Limited, Glenmark Pharmaceuticals, Alkem Laboratories, Torrent Pharmaceuticals Ltd.

A key trend in the diverticulitis disease market includes technological advancement. Major companies operating in the diverticulitis disease market are developing innovative drugs and getting them approved to sustain their position in the market. Drug development can lead to the development of more effective treatments for diverticulitis, reducing the risk of complications and improving patient outcomes. For instance, in April 2023, the United States Food and Drug Administration, a US-based federal organization, approved Seres' microbiota drug for recurrent gut infections. This drug is designed to treat recurring gut infections and prevent the recurrence of Clostridioides difficile (C. diff.) infections in adults aged 18 and over. The approval of Vowst was based on a clinical trial that enrolled 346 patients with recurrent CDI. The trial found that patients who received Vowst were significantly less likely to experience a recurrence of the infection than those who received a placebo. The drug is taken orally and is based on microbiota containing Firmicutes spores, which are known to contribute to a healthy microbiome that can resist C. diff. colonization.

Read More On The Global Diverticulitis Disease Market Report Here:
https://www.thebusinessresearchcompany.com/report/diverticulitis-disease-global-market-report

The diverticulitis disease market is segmented -
• By Type: Uncomplicated, Complicated

• By Diagnosis: Computed Tomography (CT) Scan, Ultrasound, Urine Test, Blood Test

• By Treatment: Medications, Surgery, Supportive care, Penicillin Antibiotic, Antibiotics, Dietary Supplements, Intravenous (IV) Fluids

• By End-User: Specialty Centers, Hospitals, Research centers

• By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the diverticulitis disease market.

The Business Research Company's "Global Diverticulitis Disease Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.

Explore Buying Options For The Diverticulitis Disease Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12990

The Table Of Content For The Diverticulitis Disease Market Include:
1. Executive Summary
2. Diverticulitis Disease Market Characteristics
3. Diverticulitis Disease Market Trends And Strategies
4. Diverticulitis Disease Market - Macro Economic Scenario
5. Global Diverticulitis Disease Market Size and Growth
……
32. Global Diverticulitis Disease Market Competitive Benchmarking
33. Global Diverticulitis Disease Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Diverticulitis Disease Market
35. Diverticulitis Disease Market Future Outlook and Potential Analysis
36. Appendix

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.